Where it Started
Dr. El Sayed is the inventor of Oleolive's patent technology a co-founder of the company and a medicinal chemist. He is one of (if not, the most) published researchers in the field of Extra Virgin Olive Oil phenolics and an expert on oleocanthal. His discoveries have advanced our understanding of oleocanthal's mechanism of action, safety profiles, anti-neoplastic benefits and much more.
Dr. Kaddoumi has been with us since the beginning and was one of the first researchers to explore the cognitive enhancement benefits associated with consuming oleocanthal. She is a widely published figure in the field of Extra Virgin Olive Oil phenolics and has run multiple clinical trials assessing the effect of oleocanthal and its constituents on neurodegenerative diseases.
Oleolive, the makers of Oligen, is not a supplement or marketing company, we are a biotech company doing cutting edge research on serious diseases. We develop therapeutics for neurodegenerative diseases and rare cancers. We took this insanely high standard and applied it to the development of Oligen. Oligen has been thoroughly researched in a wide array of models from in vitro to in vivo and even clinically as oleocanthal. There are hundreds of peer reviewed and published papers on the benefits of oleocanthal consumption and we are continually looking to improve the field. Our motto since inception has been "Science First" and we stuck to it, taking four years to fully develop and commercialize our product, now known as Oligen.
As we developed Oligen, we kept a few things in mind that were important to us as a company and important to our customers. With a commitment to simplicity, Oligen boasts a carefully curated blend of four key ingredients. Firstly, our active component is a patented extract of extra virgin olive oil, produced in-house with water as the primary solvent, ensuring the delivery of the natural compound in its purest form. Complementing this is FujiCalin, our exclusive excipient—a calcium-based product at its core. In addition, there are trace amounts of PEG600, serving as an antioxidant and aiding in the distribution of active ingredients within the calcium powder, along with magnesium stearate to facilitate smooth product flow during capsule filling.
This thoughtfully composed formulation represents our dedication to providing you, our valued customer, with a product where every ingredient serves a purpose. Oligen embodies this ethos with minimal packaging, a clinical layout, and simple instructions—just two capsules per day with a meal to experience Oligen's benefits.
Guiding the company's vision and strategy as the CEO, Kiley, oversees operations and fosters innovation for sustained success.
Dr. Jim Cardelli
Jim Cardelli, the visionary Chief Technology Officer at Oleolive, Inc., leading groundbreaking research and strategic growth in the biotechnology world.
Dr. Alana Gray
As the Chief Operating Officer, Alana streamlines operations for optimal efficiency and organizational excellence, driving the company towards its goals.
Dr. Dave Coleman
As Chief Science Officer, Dave manages a wide range of responsibilities, including developing research plans and study designs, reviewing data, as well as oversees Oligen manufacturing and quality control testing. He is dedicated to developing ground-breaking solutions for debilitating ailments.
Mylinh Wark, the regulatory compliance and quality control expert at Oleolive ensures FDA compliance, safety, and product quality, while also contributing her expertise to the production of our acclaimed Oligen capsules.
Dr. Melanie Haluska
As one of our Scientist at Oleolive, Melanie drives impactful health advancements through pioneering research, encompassing cancer biology, cell biology, pre-clinical models, and targeted drug development for Alzheimer's, glioblastoma, and healthy aging.
As the Marketing Coordinator, they lead the charge in all things marketing for the company, driving growth and engagement through strategic initiatives and creative campaigns.